Evolent Health (EVH) Payables (2015 - 2026)

Evolent Health has reported Payables for 12 years, with the latest figure at $63.0 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 72.56% year-over-year to $63.0 million; the trailing twelve-month figure through Mar 2026 stood at $63.0 million (down 72.56% YoY), and the FY2025 full-year result was $59.8 million, down 77.65% from the prior year.
• Payables for Q1 2026 stood at $63.0 million, up from $59.8 million in the prior quarter.
• The five-year high for Payables was $267.5 million in Q4 2024, with the low at $39.0 million in Q2 2024.
• Average Payables over 5 years is $94.9 million, with a median of $63.0 million recorded in 2026.
• Peak annual rise in Payables reached 518.96% in 2025, while the deepest fall reached 77.65% in 2025.
• Tracing EVH's Payables over 5 years: stood at $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then surged by 454.43% to $267.5 million in 2024, then plunged by 77.65% to $59.8 million in 2025, then advanced by 5.41% to $63.0 million in 2026.
• The last three Payables figures came in at $63.0 million (Q1 2026), $59.8 million (Q4 2025), and $77.3 million (Q3 2025), per Business Quant data.

Peer Comparison